蓝丰生化：控股子公司蓝丰有限拟增资扩股

Core Viewpoint - The company announced a capital increase for its subsidiary, Jiangsu Lanfeng Biochemical Co., Ltd., to support its operational development, with a total investment of RMB 30 million [1] Group 1: Capital Increase Details - The capital increase will be conducted by one of the original shareholders, Yuanjiang Bide Chemical Co., Ltd., through a cash injection of RMB 30 million, of which RMB 3 million will be added to the registered capital and RMB 27 million to the capital reserve [1] - Other original shareholders, Anhui Xuhe Capital Holdings Co., Ltd. and Jiangsu Suhua Group Co., Ltd., will waive their preferential subscription rights for this capital increase [1] Group 2: Impact on Shareholding Structure - Following the completion of the capital increase, the registered capital of Lanfeng Biochemical will rise from RMB 130 million to RMB 133 million [1] - The company's ownership stake in Lanfeng Biochemical will decrease from 76.92% to 75.19%, but Lanfeng Biochemical will remain a subsidiary controlled by the company, and there will be no change in the scope of the company's consolidated financial statements [1]